Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients.
from The Medical News http://ift.tt/1Gqb8tr
from The Medical News http://ift.tt/1Gqb8tr
No comments:
Post a Comment